Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CPT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Carnitine Palmitoyltransferase 2 - mitochondrial enzyme critical for fatty acid beta-oxidation, with links to neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's disease
| Gene Symbol | CPT2 |
| Aliases | Carnitine Palmitoyltransferase 2 |
| Chromosome | 1p32.3 |
| Protein Type | Enzyme |
| Function | encodes a mitochondrial enzyme that catalyzes the conversion of acylcarnitine esters back to free carnitine and fatty acyl-CoA esters. |
| Amino Acids | 659 aa |
| Pathways | Amyloid, Lipid Metabolism, Mitochondrial Function, Oxidative Phosphorylation |
| Ensembl ID | ENSG00000157184 |
| GeneCards | CPT2 |
| Human Protein Atlas | CPT2 |
| Transmembrane anchor | A single transmembrane helix that localizes the protein to the inner mitochondrial membrane |
| Catalytic domain | The bulk of the protein faces the mitochondrial matrix where catalysis occurs |
| Substrate binding pocket | Contains residues for carnitine and acyl-CoA binding |
| Associated Diseases | Als, Cancer, Cardiac, Heart Failure, Tumor |
| Interactions | SLC44A2, MUL1, PVALB, SST, IDH2, TAU |
| KG Connections | 73 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CPT2["<b>CPT2</b>"]
Ms{"Ms"}
CPT2 -->|"inhibits"| Ms
Cancer{"Cancer"}
CPT2 -->|"inhibits"| Cancer
Tumor{"Tumor"}
CPT2 -->|"inhibits"| Tumor
CANCER["CANCER"]
CPT2 -->|"inhibits"| CANCER
SLC44A2["SLC44A2"]
CPT2 -->|"inhibits"| SLC44A2
MUL1["MUL1"]
CPT2 -->|"activates"| MUL1
neurodegeneration["neurodegeneration"]
CPT2 -->|"implicated in"| neurodegeneration
UBIQUITIN["UBIQUITIN"]
UBIQUITIN -->|"activates"| CPT2
style CPT2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Ms | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Heart Failure | implicated_in | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| Cardiac | implicated_in | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| SLC44A2 | inhibits | gene | 0.60 |
| MUL1 | activates | gene | 0.60 |
| USP30 | implicated_in | gene | 0.60 |
| PARKIN | implicated_in | gene | 0.60 |
| HSPA1A | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| IDH2 | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| CACNA2D2 | associated_with | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| MITOCHONDRIA | inhibits | gene | 0.60 |
| Mitophagy | inhibits | pathway | 0.60 |
| GENES | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| Lipid Metabolism | associated_with | pathway | 0.60 |
| Mapk | associated_with | pathway | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| Lipid Metabolism | activates | pathway | 0.60 |
| Mitochondrial Function | activates | pathway | 0.60 |
| Oligodendrocyte | activates | cell_type | 0.60 |
| Microglia | activates | cell_type | 0.60 |
| Neuron | activates | cell_type | 0.60 |
| AND | activates | gene | 0.60 |
| AMYLOID-Β PLAQUES | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| Oxidative Phosphorylation | activates | pathway | 0.60 |
| Amyloid | activates | pathway | 0.60 |
| Ras | activates | protein | 0.60 |
| CPT1A | associated_with | gene | 0.60 |
| Oligodendrocyte | expressed_in | cell_type | 0.55 |
| Neuron | expressed_in | cell_type | 0.55 |
| Microglia | expressed_in | cell_type | 0.55 |
| PVALB | activates | gene | 0.50 |
| SST | activates | gene | 0.50 |
| GENES | co_discussed | gene | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| UBIQUITIN | activates | gene | 0.60 |
| PINK1 | implicated_in | gene | 0.60 |
| PARL | implicated_in | gene | 0.60 |
| MAPK1 | associated_with | gene | 0.60 |
| HDAC3 | associated_with | gene | 0.60 |
| CRYAB | associated_with | gene | 0.60 |
| IDH2 | activates | gene | 0.60 |
| SST | activates | gene | 0.60 |
| PVALB | activates | gene | 0.60 |
| CACNB3 | associated_with | gene | 0.60 |
| ADRB1 | associated_with | gene | 0.60 |
| MITOPHAGY | inhibits | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| TAU PATHOLOGY | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| CDH1 | therapeutic_target | gene | 0.60 |
| PER | therapeutic_target | gene | 0.60 |
| AGING | therapeutic_target | gene | 0.60 |
| TAU | activates | protein | 0.50 |
| ALZHEIMER | activates | gene | 0.50 |
| AMYLOID | activates | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||